Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced liver disease.

H J Zimmerman

    Drugs
    |July 1, 1978
    PubMed
    Summary

    Drug-induced liver injury can be predictable (intrinsic hepatotoxins) or unpredictable (idiosyncratic). Understanding these mechanisms is key to identifying and managing various forms of hepatic injury from chemical agents.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Encephalomyeloradiculitis (Guillain-Barré syndrome) as a complication of infectious hepatitis.

    Annals of internal medicine·2010
    Same author

    Infectious hepatitis; clinical and laboratory features of 295 cases.

    The American journal of the medical sciences·2010
    Same author

    Drug- and chemical-induced cholestasis.

    Clinics in liver disease·2001
    Same author

    Drug-induced liver disease.

    Clinics in liver disease·2001
    Same author

    Management of drug-induced liver disease.

    Current gastroenterology reports·2001
    Same author

    Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children.

    The Journal of pediatrics·1998

    Area of Science:

    • Hepatology
    • Toxicology
    • Pharmacology

    Background:

    • Numerous chemical agents used therapeutically or diagnostically can cause liver injury through diverse mechanisms.
    • Drug-induced hepatic injury manifests as acute (cytotoxic, cholestatic, mixed) or chronic (hepatitis, steatosis, cirrhosis, etc.) lesions.
    • Understanding the relationship between drug properties and liver damage is crucial for clinical management.

    Purpose of the Study:

    • To elucidate the mechanisms underlying drug-induced hepatic injury.
    • To differentiate between intrinsic (predictable) and idiosyncratic (unpredictable) hepatotoxicity.
    • To categorize hepatotoxic agents based on their mode of action and clinical presentation.

    Main Methods:

    • Review and classification of known hepatotoxic agents based on their chemical properties and observed liver damage.
    • Analysis of the mechanisms of direct and indirect hepatotoxicity, including cytotoxic and cholestatic pathways.
    • Examination of host factors, such as allergy and metabolic aberrations, contributing to idiosyncratic drug reactions.

    Main Results:

    • Intrinsic hepatotoxins are dose-dependent and reproducible, causing direct or indirect cellular damage (necrosis, steatosis) or bile flow obstruction.
    • Indirect hepatotoxins can be cytotoxic (e.g., antineoplastics) or cholestatic (e.g., C-17 alkylated steroids).
    • Idiosyncratic drug-induced liver injury, often due to host susceptibility (allergy or metabolic issues), accounts for most cases.

    Conclusions:

    • Drug-induced hepatic injury results from predictable intrinsic toxicity or unpredictable idiosyncratic reactions.
    • Classification of hepatotoxins aids in understanding the pathogenesis of liver damage.
    • Host factors play a significant role in the development of idiosyncratic drug-induced liver injury.

    Related Experiment Videos